GPN vs ORMP
Global Payments Inc (GPN) versus Oramed Pharmaceuticals Inc (ORMP) — a side-by-side from cached financials, not a winner call.
Global Payments Inc (GPN) is a specialty business services company listed on US.
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.
Latest reported GPN revenue for 2024-12-31 was $10.11B. Net income was $1.64B. Revenue was up 4.7% from 2023-12-31 to 2024-12-31. GPN currently screens at market cap $18.14B and trailing P/E 24.4.
Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.
GPN currently screens at market cap $18.14B and trailing P/E 24.4. ORMP currently screens at market cap $87.2M.
Not investment advice. Open the GPN and ORMP stock pages for the full models.
Not investment advice.